Somatic mutations in protein phosphatase Mg2+/Mn2+ dependent 1D (Ppm1d), that frequently occur in cancer survivors with t-CH, contribute to the development of nonischemic heart failure in a murine model. This evidence concerns the gene PPM1D and cyclic hematopoiesis.